Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, the
incidence of thromboembolism has been increasingly reported. The aim of this systematic …

Cancer patients often have an activated clotting system and are at increased risk for venous
thrombosis. In the present study, we analyzed tissue factor (TF) expression in 4 different …

Activation of coagulation and vascular inflammation are prominent features of sickle cell
disease (SCD). Previously, we have shown that inhibition of tissue factor (TF) attenuates …

Sickle cell disease (SCD) is associated with a complex vascular pathophysiology that
includes activation of coagulation and inflammation. However, the crosstalk between these 2 …

An excess of free heme is present in the blood during many types of hemolytic anemia. This
has been linked to organ damage caused by heme-mediated oxidative stress and vascular …

Microparticles (MPs) are cellular vesicles produced by all cells in response to apoptosis or
cellular activation. In this brief review, the evidence that MPs mediate the thrombotic …

Objectives Standard treatment with a thiotepa-based regimen in countries with a limited
resource is less feasible. Aims of the study were to evaluate the treatment outcome, and identify …

Sickle cell anemia is an inherited hematologic disorder associated with hemolytic and vaso-occlusive
complications. An activation of coagulation is also a prominent feature of sickle cell …

Background Cytogenetic abnormalities and mutated genes indicate the role of consolidation
therapy with hematopoietic stem cell transplantation (HSCT) or chemotherapy in acute …

INTRODUCTION: Promoting thrombin generation by inhibiting tissue factor pathway inhibitor
(TFPI) is a potentially viable therapeutic approach to the prevention and/or treatment of …